Education
About Us
Working with TipRanks
Follow Us
Cedric Francois Insider Profile
4 Followers
Cedric Francois, CEO, Director at Apellis Pharmaceuticals, holds 1.87M shares in Apellis Pharmaceuticals (Ticker: APLS).
Cedric Francois Apellis Pharmaceuticals (APLS)CEO, Director
Apellis Pharmaceuticals (APLS)
CEO, Director
Ranked #3,756 out of 102,596 Corporate Insiders
Profitable Transactions
10 out of 11 Profitable Transactions
Average Return
+34.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Cedric Francois's holdings
Insider Roles
CEO, Director
Roles that Cedric Francois holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 13, 2024 - Feb 13, 2025
Return:+58.50%
The most profitable trade made by Cedric Francois
Cedric Francois's Trading History
List of latest transactions for each holding click on a transaction to see Cedric Francois's performance on stock
You May Also Like
Cedric Francois insider profile FAQ
What is the percentage of profitable transactions made by Cedric Francois?
The percentage of profitable transactions made by Cedric Francois is 91%.
What is the average return per transaction made by Cedric Francois?
The average return per transaction made by Cedric Francois is 34.80%.
What stocks does Cedric Francois hold?
Cedric Francois holds: APLS stocks.
What was Cedric Francois’s latest transaction?
Cedric Francois latest transaction was an Uninformative Buy of $38.78K.
What was Cedric Francois's most profitable transaction?
Cedric Francois’s most profitable transaction was an Informative Sell of APLS stock on February 13, 2024. The return on the trade was 58.50%.
What is Cedric Francois's role in Apellis Pharmaceuticals?
Cedric Francois's role in Apellis Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.